This evidence suggests that diabetic patients on insulin therapy may be more susceptible to AF-related thromboembolism than individuals with less severe forms of diabetes usually not requiring insulin, as shown in the PREFER in AF (European Prevention of Thromboembolic Events—European Registry in Atrial Fibrillation) registry [19]. This evidence concerns the gene INS and diabetes mellitus.